1. Erratum to: Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer. Issue 1 (December 2015) Authors: Wang, Bi-Yun; Zhang, Jian; Wang, Jia-Lei; Sun, Si; Wang, Zhong-Hua; Wang, Lei-Ping; Zhang, Qun-Ling; Lv, Fang-Fang; Cao, En-Ying; Shao, Zhi-Min; Fais, Stefano; Hu, Xi-Chun Journal: Journal of experimental & clinical cancer research Issue: Volume 34:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer. Issue 1 (December 2015) Authors: Wang, Bi-Yun; Zhang, Jian; Wang, Jia-Lei; Sun, Si; Wang, Zhong-Hua; Wang, Lei-Ping; Zhang, Qun-Ling; Lv, Fang-Fang; Cao, En-Ying; Shao, Zhi-Min; Fais, Stefano; Hu, Xi-Chun Journal: Journal of experimental & clinical cancer research Issue: Volume 34:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer. Issue 1 (December 2015) Authors: Wang, Bi-Yun; Zhang, Jian; Wang, Jia-Lei; Sun, Si; Wang, Zhong-Hua; Wang, Lei-Ping; Zhang, Qun-Ling; Lv, Fang-Fang; Cao, En-Ying; Shao, Zhi-Min; Fais, Stefano; Hu, Xi-Chun Journal: Journal of experimental & clinical cancer research Issue: Volume 34:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗